An Open-Label Exploratory Analysis of Commercial Probiotics in Adults With Rheumatoid Arthritis
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Be able to give written informed consent.
• Be 18 years or older.
• Clinical diagnosis of rheumatoid arthritis (RA) for more than 6 months.
• Have been on stable RA treatment for 3 months and are expected to remain on stable RA treatment during the study.
• Willing to consume the study product daily for the duration of the study.
Locations
United States
Illinois
Atlantia Clinical Trials
RECRUITING
Chicago
Contact Information
Primary
Stacey Boetto, DNP, FNP-C
sboetto@atlantiatrials.com
312-535-9440
Time Frame
Start Date: 2025-11-13
Estimated Completion Date: 2026-03
Participants
Target number of participants: 50
Treatments
Experimental: Probiotic
6-week daily oral administration of Align Extra Strength Probiotic Supplement, produced by Procter \& Gamble (Bifidobacterium longum subsp. longum 35624™)
Related Therapeutic Areas
Sponsors
Leads: Ancilia Biosciences